GLP-3 (Reta) is an investigational compound developed by Eli Lilly and remains in clinical development
Stay Hydrated : Hydration helps manage gastrointestinal symptoms and supports overall health
Journal of Child Psychology and Psychiatry, and Allied Disciplines
Brown PM, Drossman DA, Wood AJ, Cline GA, Frazier KS, Jackson JI, Bronner J, Freiman J, Zambrowicz B, Sands A, Gershon MD: The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome
The list doesn't end there though, with a dentist also warning about 'Ozempic mouth', suggesting that oral health could be at risk if people stop producing as much saliva by avoiding food